572 related articles for article (PubMed ID: 14993453)
41. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae.
Razani B; Wang XB; Engelman JA; Battista M; Lagaud G; Zhang XL; Kneitz B; Hou H; Christ GJ; Edelmann W; Lisanti MP
Mol Cell Biol; 2002 Apr; 22(7):2329-44. PubMed ID: 11884617
[TBL] [Abstract][Full Text] [Related]
42. Caveolae and caveolins in the cardiovascular system.
Gratton JP; Bernatchez P; Sessa WC
Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
[TBL] [Abstract][Full Text] [Related]
43. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
Sotgia F; Bonuccelli G; Minetti C; Woodman SE; Capozza F; Kemp RG; Scherer PE; Lisanti MP
Am J Pathol; 2003 Dec; 163(6):2619-34. PubMed ID: 14633633
[TBL] [Abstract][Full Text] [Related]
44. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
45. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
46. [Caveolar functions and caveolin structural proteins].
Bat'ová Z; Bittnerová M; Krenek P; Kyselovic J
Cesk Fysiol; 2003 Dec; 52(4):166-71. PubMed ID: 15027150
[TBL] [Abstract][Full Text] [Related]
47. Reduction of caveolin 1 gene expression in lung carcinoma cell lines.
Racine C; Bélanger M; Hirabayashi H; Boucher M; Chakir J; Couet J
Biochem Biophys Res Commun; 1999 Feb; 255(3):580-6. PubMed ID: 10049753
[TBL] [Abstract][Full Text] [Related]
48. Cell biology of caveolae and caveolin.
Couet J; Belanger MM; Roussel E; Drolet MC
Adv Drug Deliv Rev; 2001 Jul; 49(3):223-35. PubMed ID: 11551396
[TBL] [Abstract][Full Text] [Related]
49. Caveolin-1 as a potential new therapeutic target in multiple myeloma.
Podar K; Anderson KC
Cancer Lett; 2006 Feb; 233(1):10-5. PubMed ID: 16473666
[TBL] [Abstract][Full Text] [Related]
50. Identification of caveolae and their signature proteins caveolin 1 and 2 in the lens.
Lo WK; Zhou CJ; Reddan J
Exp Eye Res; 2004 Oct; 79(4):487-98. PubMed ID: 15381033
[TBL] [Abstract][Full Text] [Related]
51. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3.
Hernández-Deviez DJ; Martin S; Laval SH; Lo HP; Cooper ST; North KN; Bushby K; Parton RG
Hum Mol Genet; 2006 Jan; 15(1):129-42. PubMed ID: 16319126
[TBL] [Abstract][Full Text] [Related]
52. Raft association and lipid droplet targeting of flotillins are independent of caveolin.
Rajendran L; Le Lay S; Illges H
Biol Chem; 2007 Mar; 388(3):307-14. PubMed ID: 17338638
[TBL] [Abstract][Full Text] [Related]
53. Caveolae, lipid rafts, and vascular disease.
Li XA; Everson WV; Smart EJ
Trends Cardiovasc Med; 2005 Apr; 15(3):92-6. PubMed ID: 16039968
[TBL] [Abstract][Full Text] [Related]
54. Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells.
Smythe GM; Rando TA
Exp Cell Res; 2006 Sep; 312(15):2816-25. PubMed ID: 16814768
[TBL] [Abstract][Full Text] [Related]
55. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1.
Bender F; Montoya M; Monardes V; Leyton L; Quest AF
Biol Res; 2002; 35(2):151-67. PubMed ID: 12415732
[TBL] [Abstract][Full Text] [Related]
56. Caveolae in human and murine osteoblasts.
Solomon KR; Adolphson LD; Wank DA; McHugh KP; Hauschka PV
J Bone Miner Res; 2000 Dec; 15(12):2391-401. PubMed ID: 11127204
[TBL] [Abstract][Full Text] [Related]
57. Cavin proteins: New players in the caveolae field.
Briand N; Dugail I; Le Lay S
Biochimie; 2011 Jan; 93(1):71-7. PubMed ID: 20363285
[TBL] [Abstract][Full Text] [Related]
58. Morphologic and functional characterization of caveolae in rat liver hepatocytes.
Calvo M; Tebar F; Lopez-Iglesias C; Enrich C
Hepatology; 2001 May; 33(5):1259-69. PubMed ID: 11343255
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.
Patlolla JM; Swamy MV; Raju J; Rao CV
Oncol Rep; 2004 May; 11(5):957-63. PubMed ID: 15069532
[TBL] [Abstract][Full Text] [Related]
60. Consequences of a novel caveolin-3 mutation in a large German family.
Fischer D; Schroers A; Blümcke I; Urbach H; Zerres K; Mortier W; Vorgerd M; Schröder R
Ann Neurol; 2003 Feb; 53(2):233-41. PubMed ID: 12557291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
